Professor Jonathan Ross. Dr Melinda Tenant-Flowers. University Hospitals Birmingham NHS Trust. King s College Hospital NHS Foundation Trust, London

Size: px
Start display at page:

Download "Professor Jonathan Ross. Dr Melinda Tenant-Flowers. University Hospitals Birmingham NHS Trust. King s College Hospital NHS Foundation Trust, London"

Transcription

1

2 THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Professor Jonathan Ross University Hospitals Birmingham NHS Trust Dr Melinda Tenant-Flowers King s College Hospital NHS Foundation Trust, London 1-4 April 2014, Arena and Convention Centre Liverpool

3 THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Dr John White Guy s and St Thomas NHS Foundation Trust, London 1-4 April 2014, Arena and Convention Centre Liverpool

4 THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Dr John White Guy s and St Thomas NHS Foundation Trust, London COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Dr John White Statement acts in a consultancy capacity for Diagnostics for the Real World, and as a speaker at company-sponsored events for Gilead, Becton-Dickinson, GenProbe/Hologic, and Cepheid. Date April April 2014, Arena and Convention Centre Liverpool

5 Translating recent research into clinical practice Dr John White Consultant Physician in Sexual Health & HIV Guy s and St Thomas NHS Foundation Trust 2 nd APRIL 2014

6 Translating recent research into clinical practice

7 MSM pharyngeal GC cases - GSTT 230% increase Also: 220% increase in LGV cases % increase in early syphilis last 6 months

8 Metsch LR et al. JAMA Oct 23/30, 2013 RCT to assess the effectiveness of counseling in reducing STI incidence among STD clinic patients n=5012 patients Sites included 9 STD clinics across USA

9 Metsch LR et al. JAMA Oct 23/30, Randomized to receive: brief HIV risk-reduction counseling with a rapid HIV test ($56/pt) or the rapid HIV test with information only ($23/pt) 6-mth follow up for HIV, syphilis, HSV2 (serum), genital GC/CT, TV( ) + rectal CT/GC (MSM)

10 Metsch LR et al. JAMA Oct 23/30, 2013 Results: (87% retention) incident rates: 12.3% in the counseling group 11.1% in the information-only group no overall benefit from prevention counseling observed a notable increase in STIs for MSM: 18.7% STI in counseling group vs. 12.5% in information-only group (arr, 1.41 [ ])

11 Metsch LR et al. JAMA Oct 23/30, 2013 Disappointing that counselling might not work But good for universal HIV testing: eliminate counseling in the setting of HIV screening so as to increase uptake of tests need to look for alternative effective interventions, esp MSM

12 Online survey of 2063 sexually active US MSM. Sex party attendees were more likely to be: Sex Transm Infect 2014;90:26 32 HIV-positive (28.1%), single (31.7%), have sexual compulsivity (39.2%), recently used drugs (67.8%), more partners (med=15, <90 days), and more UAI (median=3, <90 days)

13 Sex Transm Infect 2014;90: % expressed interest in free rapid HIV testing at sex parties But few considered it acceptable to see medical providers (11.7%) and peer outreach workers (9.5%) at sex parties

14 Sex Transm Infect 2014;0:1 7. included 11 studies representing sexual encounters. (USA, Canada, UK, & Australia/NZ) Odds for any UAI, seroconcordant UAI and serodiscordant UAI with strategic positioning were higher in online-initiated sexual encounters

15 Sex Transm Infect 2014;0:1 7. Singaporean heterosexual men aged years Compared online vs. brothel patrons Men seeking sex online reported significantly higher rates of oral and anal sex, STIs, lower condom use for oral sex with CSW (16.5% vs 56.6%)

16 Buri ER et al. Sex Transm Dis Vol 40;7, July 2013 n=273 aged 13 to 19 years - teen clinic in Florida. Completed ACASI, urine screening CT/GC 42 teens (15%) reported they had sex with a person they first met online though no more likely to have ever or currently have an STD

17 Centralization of PN services New staff; addition of internet/ to text messaging for PN 362 contacts were initiated compared with 133 in previous year Sex Transm Dis Vol 41;2, Feb new HIV, 11 new syphilis, and 19 known previous HIV-positive persons were identified.

18 Hunter P. et al. Public Health Reports; 2014 Supp 1;Vol 129 Investigation of syphilis outbreak in young black MSM in US

19 Hunter P. et al. Public Health Reports; 2014

20 John White updated his profile picture

21 Chesson HW et al, Sex Transm Dis Vol 40;5, May 2013 Modelling study; based on San Fran data Screening & treating MSM for rectal CT/GC may help reduce increased biological susceptibility to HIV identify men at increased risk for HIV

22 Chesson HW et al, Sex Transm Dis Vol 40;5, May 2013 Cost per QALY gained was $16,300 in the static model In the dynamic model, the cost per QALY gained was less than $0, meaning that rectal screening was costsaving assumed all rectal CT/GC infections detected would be treated successfully immediately upon detection lots of assumptions but important in MSM

23 Retrospective cohort of male patients diagnosed with rectal chlamydia Sex Transm Dis Feb;41(2): (culture); APTIMA Combo 2 Treated with azithromycin (1 g stat) or doxycycline (100 mg bd 7 days)

24 n=1835 cases of rectal chlamydia Sex Transm Dis Feb;41(2): /1231 (33%) of AZI and 95/249 (38%) of DOXY men had a repeat test within 14 to 180 days (median 84 days; P = 0.12) DOXY men more likely to have a symptomatic infection and diagnosis of proctitis (both P<0.01)

25 Treatment with AZI significantly associated with a 5-fold higher risk of persistent/recurrent infection at 14 to 90 days after treatment c.f. DOXY Overall failure rates at days: 88/407 (21.6%) AZI-treated 8/95 (8.4%) DOXY-treated (p=0.002) Sex Transm Dis Feb;41(2):79-85

26 Azithromycin for rectal CT There have been no RCTs for antibiotic therapy of rectal CT Observations of poorer outcome with Azi 1g FIVE papers now If meta-analysis: Azi 1g 505/628 = 80.4% (95%CI ) Doxy 288/300 = 96.0% (95%CI ) Are RCTs really needed??? MSM good with pills

27 Int J STD AIDS : 822 n=143 MG+ve specimens: fluoroquinolone mutations in 15% and macrolide mutations in 43% n=30 men with MG+ve NGU 25 heterosexual; 4 MSM; 1 bisexual 2 partners (cervical MG); 1 MSM (rectal MG) 4 cases of moxifloxacin treatment failure

28 UK MSM data The Lancet Infectious Diseases 2014; 14:16-17

29 Of all patients from 17 states infected with azithromycin-resistant Shigella 36 S. flexneri, 18 S. sonnei, 1 S. boydii 80% men; 79% MSM, 81% HIV-positive MMWR Morb Mortal Wkly Rep Feb 14;63(6): % resistant to >5 classes; 4% cipro-resistant

30 Sex Transm Infect 2013;89: iv47 iv51 Core groups breed and spread resistant organisms MSM have been critical to the spread of GC resistant to cefixime and ceftriaxone Most important core group in UK Crucial to consider differently when treating

31 45% of NGU cases have no identified etiology. Novel bacteria recently associated with BV in women may be involved Cases (n = 157) with NGU (GC, CT, TV, MG, UU2-negative) vs. controls (n = 102) Urine tested by qpcr for BVABs Sex Transm Dis Vol 40;12, Dec 2013

32 Sex Transm Dis Vol 40;12, Dec 2013 Leptotrichia/Sneathia spp. were significantly associated with urethritis 24/157 (15.3%) vs. 6/102 (5.9%), P = 0.03 BVAB-2 was more common in cases BVAB-3 & Megasphaera only in men with NGU Atopobium spp. not associated with NGU

33 Sex Transm Dis Vol 40;12, Dec 2013 Among treated cases, doxycycline was more effective than azithromycin for clinical cure of men with Leptotrichia/Sneathia spp. (9/10 vs. 7/12, P = 0.16) and BVAB-2 (3/3 vs. 0/3, P = 0.10)

34 Prospective study followed women for 1 year after choosing: copper T380 IUD or oral LNG for EC n=542 women who presented for EC <120h - Salt Lake City, US 215 (40%) chose the copper IUD IUD insertion failed in 42 women (19%) 327 (60%) chose oral LNG 1-year F/U rate was 82% 64% of IUD users still had their IUDs at 1 year Turok DK, et al Contraception Mar;89(3)

35 1-year cumulative pregnancy rates: By type of EC method actually received: 5.2% for copper IUD users vs. 12.3% for oral LNG users HR 0.42 ( , p=.017) Turok DK, et al Contraception Mar;89(3)

36 Promotion of IUD for EC warranted Turok DK, et al Contraception Mar;89(3) But what are our failed insertion rates? if we tell our patients that 1 in 5 emiud insertions fail how many would still go for it??

37 Participants were customers (63% males) in a barroom in Grenoble, France. Randomized to alcoholic or placebo drink

38 Participants drank, then rated how attractive, bright, original, and funny they felt at the moment estimated blood alcohol level using a breathalyser evaluated by independent judges

39 Conclusion: when people drink alcohol, they evaluate themselves as more attractive (or at least, less unattractive), but this selfperception appears to be an illusion. quantity of alcohol ingested was not related to self-perceived attractiveness

40

Dr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

Dr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Dr Selena Singh Guy s and St Thomas NHS Foundation Trust, London 1-4 April 2014, Arena and Convention Centre Liverpool Performance of ceftriaxone 500mgcontaining

More information

Answers to those burning questions -

Answers to those burning questions - Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department

More information

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.? BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection

More information

One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection

One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection A Elgalib, A Skingsley, O Dosekun, S Alexander, CYW Tong, JA White. Ali Elgalib Consultant in GUM/HIV

More information

Clinical Guidelines Update (aka Know Your NAATs)

Clinical Guidelines Update (aka Know Your NAATs) Clinical Guidelines Update (aka Know Your NAATs) WARNING: contains adult themes, sexual references and pictures that may be disturbing! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz

More information

Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH

Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH Division of Infectious Diseases University of Alabama at Birmingham School of Medicine Birmingham, Alabama Outline Syphilis in all its

More information

Sexually Transmitted Infection Treatment and HIV Prevention

Sexually Transmitted Infection Treatment and HIV Prevention Sexually Transmitted Infection Treatment and HIV Prevention Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine STI Treatment and HIV Prevention.

More information

STI Indicators by STI

STI Indicators by STI STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients

More information

Extragenital Gonorrhea and Chlamydia among MSM

Extragenital Gonorrhea and Chlamydia among MSM Extragenital Gonorrhea and Chlamydia among MSM Laura Quilter, MD Infectious Disease and STD PTC Fellow University of Washington Division of Allergy and Infectious Diseases 3/28/2016 uwptc@uw.edu uwptc.org

More information

Asymptomatic lymphogranuloma venereum in known HIV positive MSM: is it more common than we think?

Asymptomatic lymphogranuloma venereum in known HIV positive MSM: is it more common than we think? Asymptomatic lymphogranuloma venereum in known HIV positive MSM: is it more common than we think? Mr Daniel Ward 1 Dr Meg Boothby 2 Dr Penny Goold 2 Dr Emma Hathorn 2 1 University of Birmingham, UK 2 Whittall

More information

Dr Edward Coughlan. Clinical Director Christchurch Sexual Health Christchurch

Dr Edward Coughlan. Clinical Director Christchurch Sexual Health Christchurch Dr Edward Coughlan Clinical Director Christchurch Sexual Health Christchurch 16:30-17:25 WS #48: Mycoplasma Genitalium - The New Black 17:35-18:30 WS #58: Mycoplasma Genitalium - The New Black (Repeated)

More information

STIs in the Indian Country

STIs in the Indian Country STIs in the Indian Country Multiple STI s and Risk for HIV Ryan Kreisberg, MPH Senior Epidemiologist, PRISM Data Manager Agenda STI/HIV Trends across the US and Arizona STIs in the Indian Country Multiple

More information

PREP CASES BREAKOUT CASE 1: COPING WITH PILL FATIGUE PE/LABS

PREP CASES BREAKOUT CASE 1: COPING WITH PILL FATIGUE PE/LABS PREP CASES BREAKOUT CASE 1: COPING WITH PILL FATIGUE 28 year-old HIV-negative MSM CC: Rectal Mass and Diarrhea x 2 weeks PMH: No chronic medical issues - Diagnosed with secondary syphilis 9 months ago

More information

Services for GLBTQ Youth

Services for GLBTQ Youth Sexual Health Care Services for GLBTQ Youth Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Commissioner of Health Buffalo, NY Agenda Introduction Epidemiology Sexual health care services for YMSM Sexual

More information

Management of NGU (Non-gonococcal urethritis)

Management of NGU (Non-gonococcal urethritis) Management of NGU (Non-gonococcal urethritis) First line Doxycycline 100mg po bd for 7 days (contra-indicated in pregnancy) Alternative regimens Azithromycin 1G po stat Azithromycin 500mg po stat, then

More information

Professor Jonathan Ross

Professor Jonathan Ross SECOND JOINT CONFERENCE OF BHIVA AND BASHH 2010 Professor Jonathan Ross Whittall Street Clinic, Birmingham COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Statement Professor Ross has received

More information

STIs: Practical Aspects of Management

STIs: Practical Aspects of Management STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS

More information

2

2 1 2 3 1. Usinger KM et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 2016; 29: 659 67. 2. Kost K et al. Estimates of contraceptive

More information

MYCOPLASMA GENITALIUM A PRACTICAL GUIDE

MYCOPLASMA GENITALIUM A PRACTICAL GUIDE MYCOPLASMA GENITALIUM A PRACTICAL GUIDE DR JENNY HAYWARD FRANZCOG FACHSHM NEW ZEALAND SEXUAL HEALTH CONFERENCE SATURDAY 9 TH SEPTEMBER 1 ACKNOWLEDGE FRUSTRATIONS AWARENESS EVOLVING AREA TESTING OFTEN MULTIPLE

More information

Lessons from MSM PrEP pilots / demonstration projects. Kevin Rebe

Lessons from MSM PrEP pilots / demonstration projects. Kevin Rebe Lessons from MSM PrEP pilots / demonstration projects Kevin Rebe rebe@anovahealth.co.za PrEP Demonstration Projects US: Multisite demonstration project in San Francisco, Miami and Washington DC. South

More information

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology

More information

Stephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os

Stephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os STD Diagnosis and Treatment Ina Park, MD, MS STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Stephanie 23 year-old female presents for contraception,

More information

STIs in Primary Care. Dr Eleanor Draeger 19 th January 2016

STIs in Primary Care. Dr Eleanor Draeger 19 th January 2016 STIs in Primary Care Dr Eleanor Draeger 19 th January 2016 Poli=cs! 2012! Health and Social Care act! Sexual Health commissioning moved to local authority! 2015! 200 million cuts to public health! 40%

More information

Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]

Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB

More information

Update on Sexually Transmitted Infections among Persons Living with HIV

Update on Sexually Transmitted Infections among Persons Living with HIV Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases Abbreviations and

More information

A Sex-informed Framework for HIV Prevention. Robert M. Grant, M.D., M.P.H. Betty Jean and Hiro Ogawa Endowed Investigator

A Sex-informed Framework for HIV Prevention. Robert M. Grant, M.D., M.P.H. Betty Jean and Hiro Ogawa Endowed Investigator A Sex-informed Framework for HIV Prevention Robert M. Grant, M.D., M.P.H. Betty Jean and Hiro Ogawa Endowed Investigator Disclosures Gilead Sciences donated study medication to US NIH for trials that I

More information

Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018

Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018 Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018 Page 1 Contents 1 Introduction Page 3 2 Contact details Page 4 3 Opening hours Page 4 4 Services provided

More information

Disclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None

Disclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None Disclosures None What s New in the 2015 CDC STD Treatment Guidelines Ina Park, MD, MS California STD/HIV Prevention Training Center UCSF Dept of Family and Community Medicine STD Control Branch California

More information

Pre-exposure Prophylaxis for HIV Prevention

Pre-exposure Prophylaxis for HIV Prevention Mountain West AIDS Education and Training Center Pre-exposure Prophylaxis for HIV Prevention Concerns about PrEP: Sexual Behavior and STIs Joanne Stekler, MD MPH May 19, 2016 This presentation is intended

More information

Edward W. Hook, III, M.D.

Edward W. Hook, III, M.D. Challenging Cases Edward W. Hook III M.D. Professor and Director Division of Infectious Diseases University of Alabama at Birmingham And PI, Alabama/North Carolina STD PTC Edward W. Hook, III, M.D. Grant/Research

More information

RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS

RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS Warning: contains sexual themes and references! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz Updates

More information

The Impact of HIV Risk Reduction Behaviours on Sexually Transmissible Infections in HIV Negative Homosexual Men

The Impact of HIV Risk Reduction Behaviours on Sexually Transmissible Infections in HIV Negative Homosexual Men The Impact of HIV Risk Reduction Behaviours on Sexually Transmissible Infections in HIV egative Homosexual Men Fengyi Jin 1,2, Garrett P Prestage 1, David J Templeton 1,3, Basil Donovan 1,4, John Imrie

More information

5/1/2017. Sexually Transmitted Diseases Burning Questions

5/1/2017. Sexually Transmitted Diseases Burning Questions Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial

More information

Dr Claudia Estcourt. Barts and the London School of Medicine and Dentistry THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

Dr Claudia Estcourt. Barts and the London School of Medicine and Dentistry THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Dr Claudia Estcourt Barts and the London School of Medicine and Dentistry 1-4 April 2014, Arena and Convention Centre Liverpool Preventing STI Re-infection

More information

Ask at Least Annually. Ask Older Adults. Have you been sexually active in the last year? Have you ever been sexually active?

Ask at Least Annually. Ask Older Adults. Have you been sexually active in the last year? Have you ever been sexually active? Essential Sexual Health Questions to Ask Adults Ask all of your adult patients the sexual health questions on this card. They will help you assess the patient s level of sexual risk and determine whether

More information

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and 1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship

More information

GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016

GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016 GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016 TOPICS FOR DISCUSSION What medical providers should know

More information

Best Practices in STD Partner Management

Best Practices in STD Partner Management Best Practices in STD Partner Management An Overview of Patient-Delivered Partner Therapy (PDPT) and Counseling for Partner Notification and Treatment Amber Eisenmann, MS Director of Learning Exchange

More information

Incidence des IST chez les PrEPeurs

Incidence des IST chez les PrEPeurs Incidence des IST chez les PrEPeurs Jean-Michel Molina Hopital Saint-Louis, Université de Paris Diderot, Inserm U941, Paris, France PrEP, IST et Santé Sexuelle, 29 Mars 2018, Paris La PrEP en France Début

More information

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa HPTN 075 Protocol Chair: Theo Sandfort New York State Psychiatric Institute and Columbia University

More information

Azithromycin for Rectal Chlamydia: Is it Time to Leave Azithromycin on the Shelf?...Not Yet. Jordan, Stephen J. MD, PhD; Geisler, William M.

Azithromycin for Rectal Chlamydia: Is it Time to Leave Azithromycin on the Shelf?...Not Yet. Jordan, Stephen J. MD, PhD; Geisler, William M. Azithromycin for Rectal Chlamydia: Is it Time to Leave Azithromycin on the Shelf?...Not Yet Jordan, Stephen J. MD, PhD; Geisler, William M. MD, MPH From the Department of Medicine, University of Alabama

More information

The Resurgence of Syphilis in British Columbia: Who is affected? What are the challenges? How can we improve our response?

The Resurgence of Syphilis in British Columbia: Who is affected? What are the challenges? How can we improve our response? The Resurgence of Syphilis in British Columbia: Who is affected? What are the challenges? How can we improve our response? Gillian Hill-Carroll Travis Salway Hottes Pacific AIDS Network Webinar Series

More information

Ron Gray, MBBS, MFCM, MSc Johns Hopkins University. STIs in an International Setting

Ron Gray, MBBS, MFCM, MSc Johns Hopkins University. STIs in an International Setting This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

STI control. Dr. Jane Morgan Hamilton Sexual Health Clinic

STI control. Dr. Jane Morgan Hamilton Sexual Health Clinic STI control Dr. Jane Morgan Hamilton Sexual Health Clinic Overview STI control in theory NZ s reality Where to from here? STI control framework R0=ßcD R0 = reproductive rate; the rate at which infection

More information

Mycoplasma genitalium:

Mycoplasma genitalium: Mycoplasma genitalium: What is it and why should we care? Lisa E. Manhart, PhD, MPH rwpoll.com uwecho Last Updated: 09-26-2016 uwptc@uw.edu uwptc.org 206-685-9850 Disclosures Service on a scientific advisory

More information

Family Planning and Sexually Transmitted. Infections, including HIV

Family Planning and Sexually Transmitted. Infections, including HIV Infections, including HIV Family Planning and Sexually Transmitted Introduction To protect themselves, people need correct information about sexually transmitted infections (STIs), including HIV. Women

More information

Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.

Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report. Disclosures Management of STIs: Challenges in Practice I have no disclosures or conflicts of interest to report. Alison O. Marshall, MSN, FNP-C Associate Professor of Practice & Director of the Family

More information

Clinical Practice Objectives

Clinical Practice Objectives STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public

More information

Sexual Health, HIV, and STDs

Sexual Health, HIV, and STDs Sexual Health, HIV, and STDs Richard J. Wolitski, PhD Deputy Director, Behavioral and Social Science Division of HIV/AIDS Prevention Centers for Disease Control & Prevention Fenway Institute, Boston, MA

More information

Fast-Track Your PrEP Knowledge. Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs

Fast-Track Your PrEP Knowledge. Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs Fast-Track Your PrEP Knowledge Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs Session objectives Increase knowledge of the basics of PrEP and clinical procedures Identify financial

More information

Medical Director, Community & Behavioral Health Clinics Department of Health and Human Services

Medical Director, Community & Behavioral Health Clinics Department of Health and Human Services Patrick F. Luedtke MD, MPH Senior Public Health Officer Medical Director, Community & Behavioral Health Clinics Department of Health and Human Services I have no relevant financial disclosures Review current

More information

Learning Objectives. STI Update. Case 1 6/1/2016

Learning Objectives. STI Update. Case 1 6/1/2016 Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe

More information

Overview. Disclosures. Sexually Transmitted Diseases: What s New in the Guidelines and Beyond?

Overview. Disclosures. Sexually Transmitted Diseases: What s New in the Guidelines and Beyond? Sexually Transmitted Diseases: What s New in the Guidelines and Beyond? Susan S. Philip, MD, MPH Director, Disease Prevention and Control Branch Population Health Division San Francisco Department of Public

More information

A healthy respect for Sexual Health. Dee Archbold CNC Princess Alexandra Sexual Health

A healthy respect for Sexual Health. Dee Archbold CNC Princess Alexandra Sexual Health 2018 A healthy respect for Sexual Health Dee Archbold CNC Princess Alexandra Sexual Health Princess Alexandra Sexual Health (PASH) Sexual health service for Metro South (estimated >1million residents and

More information

STDs among Men who Have Sex with Men (MSM), San Francisco

STDs among Men who Have Sex with Men (MSM), San Francisco STDs among Men who Have Sex with Men (MSM), San Francisco 27 212 Applied Research, Community Health Epidemiology, and Surveillance (ARCHES) Population Health Division San Francisco Department of Public

More information

What's the problem? - click where appropriate.

What's the problem? - click where appropriate. STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female

More information

Sexually Transmitted Infections. Dr. Doug McGhee Victoria STI Clinic Dr. Jennifer Ross Island Sexual Health Society

Sexually Transmitted Infections. Dr. Doug McGhee Victoria STI Clinic Dr. Jennifer Ross Island Sexual Health Society Sexually Transmitted Infections Dr. Doug McGhee Victoria STI Clinic Dr. Jennifer Ross Island Sexual Health Society ISHS vs STI Clinic Island Sexual Health Society Non-profit society Contraception, IUD,

More information

Trends in STDs among Young People in New York State

Trends in STDs among Young People in New York State Trends in STDs among Young People in New York State Kris Mesler, Bureau of Child and Adolescent Health Alison Muse, Bureau of Sexually Transmitted Disease Control New York State Department of Health Figure

More information

RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance

RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance Ina Park, MD, MS University of California San Francisco California Prevention Training Center DISCLOSURE No Relevant

More information

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.

More information

Pre-Exposure Prophylaxis (PrEP) for HIV Infection

Pre-Exposure Prophylaxis (PrEP) for HIV Infection Pre-Exposure Prophylaxis (PrEP) for HIV Infection Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Attending Physician UCLA Center AIDS Research

More information

Outline. HIV and Other Sexually Transmitted Infections. Gonorrhea Epidemiology. Epidemiology 11/2/2012

Outline. HIV and Other Sexually Transmitted Infections. Gonorrhea Epidemiology. Epidemiology 11/2/2012 HIV and Other Sexually Transmitted Infections Tanya Kowalczyk Mullins, MD, MS Division of Adolescent Medicine Cincinnati Children s Hospital Medical Center Outline Epidemiology of select STIs and HIV STIs

More information

STD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH

STD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures

More information

STI in British Columbia: Annual Surveillance Report

STI in British Columbia: Annual Surveillance Report STI in British Columbia: Annual Surveillance Report 212 Contact Information BC Centre for Disease Control Clinical Prevention Services 655 West 12th Avenue Vancouver BC V5Z 4R4 Phone: 64-77-5621 Fax: 66-77-564

More information

CLINICAL MANAGEMENT OF STDS

CLINICAL MANAGEMENT OF STDS CLINICAL MANAGEMENT OF STDS Diana Torres-Burgos MD, MPH NYC STD/HIV Prevention Training Center STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline Essential components of STD care management Sexual

More information

Simplifying Vide Contraception. University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok

Simplifying Vide Contraception. University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok Simplifying Vide Contraception University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok Background Objectives At the conclusion of this presentation participants will be able

More information

Mycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE

Mycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE Mycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE Overview Introduction to Mycoplasma genitalium Audit Objectives Standards Results Reflection AFPHM learning objectives

More information

New Guidelines for Detection and Treatment of Sexually Transmitted Infections

New Guidelines for Detection and Treatment of Sexually Transmitted Infections UCSF Controversies in Women s health December 8, 2016 San Francisco, CA New Guidelines for Detection and Treatment of Sexually Transmitted Infections Disclosure I am a litigation consultant to a law firm

More information

MSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs

MSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs Outline MSM = (at least) 9 patients /day Management in MSM&TGpopulations OPASSPUTCHAROEN M.D. CHULALONGKORNUNIVERSITY BANGKOK, TH /HIV Recreational drugs ual fluidity and HIV Risk behavior AIDS Patient

More information

Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313

Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313 Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313 Chlamydia Most frequently reported bacterial STI in the US In 2006, In U.S. 1,030,911 cases were reported. Estimated 2,291,000 infections in 14-39 year olds.

More information

Improving outcomes The UK s achievements in managing and preventing the HIV epidemic and how we should approach public health priorities

Improving outcomes The UK s achievements in managing and preventing the HIV epidemic and how we should approach public health priorities Improving outcomes The UK s achievements in managing and preventing the HIV epidemic and how we should approach public health priorities Professor Kevin Fenton Senior Advisor, Public Health England Director,

More information

ONLINE SUPPLEMENTARY MATERIALS: FILE 1

ONLINE SUPPLEMENTARY MATERIALS: FILE 1 ONLINE SUPPLEMENTARY MATERIALS: FILE 1 Clinical care pathways using chlamydia and gonorrhoea tests are evolving: point of care nucleic acid amplification tests may reduce genitourinary medicine service

More information

How is it transferred?

How is it transferred? STI s What is a STI? It is a contagious infection that is transferred from one person to another through sexual intercourse or other sexually- related behaviors. How is it transferred? The organisms live

More information

Screening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016

Screening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016 Screening & Treating Chlamydia in Primary Care Wednesday, September 21, 2016 We Want To Hear From You! Type questions into the Questions Pane at any time during this presentation Patient-Centered Primary

More information

STIs- REVISION. Prof A A Hoosen

STIs- REVISION. Prof A A Hoosen STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex

More information

Treatment Trends for South African MSM. Kevin Rebe

Treatment Trends for South African MSM. Kevin Rebe Treatment Trends for South African MSM Kevin Rebe Why MSM? MSM are at high risk of HIV transmission and acquisition Identified in current NSP for targeted health services South Africa = 10.4 to 44.5% Increased

More information

Integrating HIV Screening Into

Integrating HIV Screening Into MaxiMizing Third ParTy reimbursement for hiv TesTing Integrating HIV Screening Into Title X Services IntroductIon HIV screening services are a core family planning service, and all individuals aged 13-64

More information

Nothing to disclose.

Nothing to disclose. Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence

More information

Advances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol

Advances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Advances in STI diagnostics Dr Paddy Horner Consultant Senior Lecturer University of Bristol Advances in STI diagnostics Rapid expansion in on-line STI testing Outstripping NHS expert advice Increasing

More information

STI & HIV screening in Primary Care. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council

STI & HIV screening in Primary Care. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council STI & HIV screening in Primary Care Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council Outline Why Screen Advances in diagnostics how can we

More information

Improving Patient Engagement in HIV Care: Health Department Strategies

Improving Patient Engagement in HIV Care: Health Department Strategies University of Washington Public Health Capacity Building Center Improving Patient Engagement in HIV Care: Health Department Strategies Julie Dombrowski, MD, MPH Deputy Director, PHSKC HIV/STD Program Assistant

More information

HIV & Condomless Sex - What is the Risk? Why Not? Alan J. Taege, MD Assistant Professor of Medicine Department of Infectious Disease Cleveland Clinic

HIV & Condomless Sex - What is the Risk? Why Not? Alan J. Taege, MD Assistant Professor of Medicine Department of Infectious Disease Cleveland Clinic HIV & Condomless Sex - What is the Risk? Why Not? Alan J. Taege, MD Assistant Professor of Medicine Department of Infectious Disease Cleveland Clinic Yes No What s Going on Out There? Condomless Sex among

More information

Cost-effectiveness of abandoning microscopy of urethral smears for asymptomatic nonchlamydial non-gonococcal urethritis in men in the UK

Cost-effectiveness of abandoning microscopy of urethral smears for asymptomatic nonchlamydial non-gonococcal urethritis in men in the UK Cost-effectiveness of abandoning microscopy of urethral smears for asymptomatic nonchlamydial non-gonococcal urethritis in men in the UK Appendix 1 Model Assumptions All assumptions were confirmed and

More information

Testing, Treating and Managing STIs Dr Jean Irvine

Testing, Treating and Managing STIs Dr Jean Irvine Testing, Treating and Managing STIs Dr Jean Irvine 1 Chlamydia 2 3 Chlamydia: key facts Intracellular bacterial infection Sexually transmitted: Vaginal sex Anal sex?oral sex Most common bacterial STI in

More information

Where are we going after effectiveness studies?

Where are we going after effectiveness studies? Where are we going after effectiveness studies? Nyaradzo M. Mgodi (MBChB, MMed) UZ-UCSF Collaborative Research Program Harare, Zimbabwe MTN Annual Meeting 28 March 2011, Arlington, VA Introduction 30 years

More information

Sexually Transmitted Diseases

Sexually Transmitted Diseases Sexually Transmitted Diseases Ina Park, MD, MS California Prevention Training Center University of California San Francisco Dept of Family and Community Medicine Disclosures/Disclaimers No disclosures

More information

STI 2016: Where We Need to Go

STI 2016: Where We Need to Go STI 2016: Where We Need to Go Gail Bolan, M.D. Director, Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and Prevention Sexually

More information

PrEP efficacy the evidence

PrEP efficacy the evidence PrEP efficacy the evidence Dr Michael Brady Consultant, HIV and Sexual Health King s College Hospital, London Medical Director Terrence Higgins Trust PrEP Pre-exposure prophylaxis Tenofovir and emtricitabine

More information

Cohorts and Capacity Kenya

Cohorts and Capacity Kenya Cohorts and Capacity Kenya Dr Joshua Kimani HIV Prevention/Care Program with Most At Risk Populations ( SW,MSM, DU) University of Manitoba / University of Nairobi Program Nairobi -Pop 42 Millions -103000

More information

STI & HIV PRE-TEST ANSWER KEY

STI & HIV PRE-TEST ANSWER KEY Name: STI & HIV PRE-TEST ANSWER KEY 1. You can catch a STI or HIV from door knobs, toilet seats, or FALSE drinking fountains. STIs are transmitted sexually, requiring sexual contact. Some STIs can be transmitted

More information

Extragenital Chlamydia and Gonorrhea. Angel Stachnik, MPH Sr. Epidemiologist Office of Epidemiology and Disease Surveillance

Extragenital Chlamydia and Gonorrhea. Angel Stachnik, MPH Sr. Epidemiologist Office of Epidemiology and Disease Surveillance Extragenital Chlamydia and Gonorrhea Angel Stachnik, MPH Sr. Epidemiologist Office of Epidemiology and Disease Surveillance Rate of Chlamydia (CT) and Gonorrhea (GC), Clark County, 2012-2016 600 Rate per

More information

Name: Date of Birth: Age: Grade: ID Number: Bob M Jones 4/21/ Gender: Sexual Orientation: Sex at Birth: Preferred Pronoun:

Name: Date of Birth: Age: Grade: ID Number: Bob M Jones 4/21/ Gender: Sexual Orientation: Sex at Birth: Preferred Pronoun: JUST HEALTH PATIENT REPORT Name: Date of Birth: Age: Grade: ID Number: Bob M Jones 4/21/2000 17 12 1234567 Gender: Sexual Orientation: Sex at Birth: Preferred Pronoun: Femal Gay or Lesbian Female No pronouns,

More information

PrEP for Women: HIV Prevention in Family Planning Settings

PrEP for Women: HIV Prevention in Family Planning Settings National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention PrEP for Women: HIV Prevention in Family Planning Settings Dawn K. Smith, MD, MS, MPH Division of HIV/AIDS Prevention dsmith1@cdc.gov

More information

10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE GOAL

10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE GOAL PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES Jade Feller, PharmD PGY-1 Pharmacy Resident Iowa City Veterans Affairs Health Care System November 13, 2018 DISCLOSURE

More information

STDs and Hepatitis C

STDs and Hepatitis C STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk

More information

Pre-exposure Prophylaxis. Robert M Grant October 2014

Pre-exposure Prophylaxis. Robert M Grant October 2014 Pre-exposure Prophylaxis Robert M Grant October 2014 The HIV Pandemic 2.3 Million New HIV Infections in 2012 39% in Young People (ages 15-24) The HIV Pandemic 1.6 Million Started Therapy in 2012 1.4 New

More information

Acute Communicable Disease Outbreaks among MSM, 2016

Acute Communicable Disease Outbreaks among MSM, 2016 Acute Communicable Disease Outbreaks among MSM, 2016 Benjamin Schwartz, MD Acute Communicable Disease Control Program Los Angeles County Department of Public Health bschwartz@ph.lacounty.gov (213) 240-7941

More information

Overview. Disclosures. Sexually Transmitted Diseases: Key Clinical Information for 2017

Overview. Disclosures. Sexually Transmitted Diseases: Key Clinical Information for 2017 Sexually Transmitted Diseases: Key Clinical Information for 2017 Susan S. Philip, MD, MPH Director, Disease Prevention and Control Branch Population Health Division San Francisco Department of Public Health

More information

INTRAUTERINE DEVICES AND INFECTIONS. Tips for Evaluation and Management

INTRAUTERINE DEVICES AND INFECTIONS. Tips for Evaluation and Management INTRAUTERINE DEVICES AND INFECTIONS Tips for Evaluation and Management Objectives At the end of this presentation, the participant should be able to: 1. Diagnose infection after IUD placement 2. Provide

More information

Sexually Transmitted Infections in Vulnerable Groups. Kevin Rebe

Sexually Transmitted Infections in Vulnerable Groups. Kevin Rebe Sexually Transmitted Infections in Vulnerable Groups Kevin Rebe Definition: Key Populations Key populations are: Defined groups who, due to specific higher-risk behaviours, are at increased Men risk who

More information